Articles From: Sorrento and Conkwest Announce Exclusive Global Collaboration to ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases


2014/12/19
Developing Next Generation Cancer Immunotherapy with "Off-the-Shelf" Chimeric Antigen Receptor-Tumor Attacking Natural Killer (CAR-TNK™) Cell Lines SAN DIEGO and CARDIFF-BY-THE-SEA, Calif.
Sign-up for Sorrento and Conkwest Announce Exclusive Global Collaboration investment picks
STOCKHOLM, Sweden, Dec.
Sign-up for Neonode(R) to Present at Needham Annual Growth Conference on January 15, 2015 investment picks
2014/12/19
By Jake Lingeman New Stingray Z06 performance specs will blow your mind The 2015 Chevy Corvette Z06 will come out of the box with a sub-3-second 0-60 time and sub-11-second quarter-mile time.
Sign-up for UPDATE: This Corvette is faster than Hellcat, Ferrari, McLaren investment picks
SAN CLEMENTE, Calif., Dec.
Sign-up for CareTrust REIT Closes on $7.2 Million Memory Care Investment investment picks
Life Time Fitness (NYSE: LTM): WHAT: New Year’s Resolutions: We all know they’re going to happen yet only 8% who make them actually keep them.
Sign-up for Forget Resolutions! Life Time Fitness South Tulsa Opens Doors to Everyone Ready to Make a Healthy Commitment Jan. 1 to 4 investment picks
2014/12/19
By David Weidner, MarketWatch Opinion: The Fed rolls back another law aimed at protecting taxpayers SAN FRANCISCO (MarketWatch) -- Crisis?
Sign-up for Regulatory recession amnesia investment picks
2014/12/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0985005001&sourceType=1 http://www.ccnmatthews.com/logos2/223mmt.jpg CALGARY, ALBERTA --
Sign-up for Correction From Source-Mart Resources, Inc.: Operations and Production Update investment picks
2014/12/19
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks rose Friday, with the market's benchmark moving toward its best weekly gain in a year.
Sign-up for European stocks on track for strongest week in a year investment picks
TAINAN, Taiwan, Dec.
Sign-up for Himax Technologies, Inc. to Attend Nomura@CES Conference on January 6th-7th, 2015 investment picks
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (NYSE: NTT), announced today its immediate launch of the NTT Communications API Gateway.
Sign-up for NTT Com's New API Gateway Allows Customers & Partners to Directly Manage NTT Com Services via Their Own Systems investment picks
2014/12/19
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch S&P 500 scores biggest 2-day gain in more than 12 years NEW YORK (MarketWatch) -- A surging U.S. stock market rallied to its best two-day gains in three years Thursday.
Sign-up for UPDATE: U.S. stocks within striking distance of records after monster rally investment picks
SHANGHAI , Dec.
Sign-up for Hanwha SolarOne Obtains Three-year US$87 Million Term-Loan Facility investment picks
2014/12/19
WINDSOR, Conn., Dec.
Sign-up for SS&C GlobeOp Forward Redemption Indicator investment picks
2014/12/19
By MarketWatch, MarketWatch Finish Line also likely to move on its quarterly results NEW YORK (MarketWatch) -- These stocks are likely to make moves on Friday: Nike Inc.(NKE) could see some pressure as shares fell nearly 3% in late trading after the company post a strong second-quarter earnings beat on Thursday.
Sign-up for UPDATE: Earnings from Nike, BlackBerry, CarMax in focus investment picks
2014/12/19
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks climbed Friday, carrying on with a global rally in equities that's poised to leave the FTSE 100 higher for the week.
Sign-up for U.K. stocks heading toward weekly win; Next shares fall investment picks
Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc. following issuance of the proposed consent order from the U.S. Federal Trade Commission (FTC) on November 26, 2014.
Sign-up for Dr. Reddy’s Laboratories Closes the Acquisition of Habitrol® Brand from Novartis investment picks
Orosur Mining Inc. (the “Company”) (TSX: OMI) (AIM: OMI), a South American-focused gold producer, developer and explorer, is pleased to announce operating results for its second quarter ended November 30, 2014 (“Q2 2015” or “the Quarter”). Highlights Gold production of 12,854 oz (14,829 oz Q2 2014) Cash operating costs of US$984/oz (US$761/oz Q2 2014) Both production and cash operating costs are in line with original guidance, and the Company remains on track to deliver its Full Year guidance of 50,000 – 55,000 oz at a cash operating cost of US$850 - $950/oz During the Quarter Orosur extended the terms of its farm-in with Corporación Nacional del Cobre de Chile (“Codelco”) until January 2020, with an option to extend for an additional two years
Sign-up for Orosur Q2 2015 Operating Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166118&ProfileId=051205&sourceType=1 TORTOLA, BRITISH VIRGIN ISLANDS --
Sign-up for Atlas Mara Co-Nvest Limited: Share Buyback Update investment picks
2014/12/19
Global IP attorneys Murgitroyd today announced internal appointments that will provide even stronger client support as the firm continues to grow.
Sign-up for Murgitroyd Growth Spurs New Appointments investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1166119&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis plc: Update on AUY922 Development Programme investment picks
INDIANAPOLIS and LYON, France , Dec.
Sign-up for Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology investment picks
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported that Roche has announced top-line results of its Phase III MARIANNE study.
Sign-up for ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Sorrento and Conkwest Announce Exclusive Global Collaboration to ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent